ArticleCancer cell international2026
Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells.
Hany E Marei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it